Literature DB >> 28935999

Integrating a Biorepository Into the National Amyotrophic Lateral Sclerosis Registry.

D Kevin Horton1, Wendy Kaye2, Laurie Wagner2.   

Abstract

As part of our continuing effort to highlight innovative approaches to improving the health and environment of communities, the Journal is pleased to publish a bimonthly column from the Agency for Toxic Substances and Disease Registry (ATSDR). ATSDR is a federal public health agency of the U.S. Department of Health and Human Services (HHS) and shares a common office of the Director with the National Center for Environmental Health (NCEH) at the Centers for Disease Control and Prevention (CDC). ATSDR serves the public by using the best science, taking responsive public health actions, and providing trusted health information to prevent harmful exposures and diseases related to toxic substances. The purpose of this column is to inform readers of ATSDR's activities and initiatives to better understand the relationship between exposure to hazardous substances in the environment and their impact on human health and how to protect public health. We believe that the column will provide a valuable resource to our readership by helping to make known the considerable resources and expertise that ATSDR has available to assist communities, states, and others to assure good environmental health practice for all is served. The conclusions of this column are those of the author(s) and do not necessarily represent the views of ATSDR, CDC, or HHS. Kevin Horton is chief of the Environmental Health Surveillance Branch within the Division of Toxicology and Human Health Sciences at ATSDR. Wendy Kaye is a senior epidemiologist at McKing Consulting Corporation. Laurie Wagner is a research associate at McKing Consulting Corporation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28935999      PMCID: PMC5603321     

Source DB:  PubMed          Journal:  J Environ Health        ISSN: 0022-0892            Impact factor:   1.179


  10 in total

1.  The National Amyotrophic Lateral Sclerosis (ALS) Registry.

Authors:  Vinicius C Antao; D Kevin Horton
Journal:  J Environ Health       Date:  2012 Jul-Aug       Impact factor: 1.179

2.  An NCI perspective on creating sustainable biospecimen resources.

Authors:  Jimmie Vaught; Joyce Rogers; Kimberly Myers; Mark David Lim; Nicole Lockhart; Helen Moore; Sherilyn Sawyer; Jeffrey L Furman; Carolyn Compton
Journal:  J Natl Cancer Inst Monogr       Date:  2011

Review 3.  Potential Environmental Factors in Amyotrophic Lateral Sclerosis.

Authors:  Björn Oskarsson; D Kevin Horton; Hiroshi Mitsumoto
Journal:  Neurol Clin       Date:  2015-11       Impact factor: 3.806

4.  How common are the "common" neurologic disorders?

Authors:  D Hirtz; D J Thurman; K Gwinn-Hardy; M Mohamed; A R Chaudhuri; R Zalutsky
Journal:  Neurology       Date:  2007-01-30       Impact factor: 9.910

5.  Prevalence of Amyotrophic Lateral Sclerosis - United States, 2012-2013.

Authors:  Paul Mehta; Wendy Kaye; Leah Bryan; Theodore Larson; Timothy Copeland; Jennifer Wu; Oleg Muravov; Kevin Horton
Journal:  MMWR Surveill Summ       Date:  2016-08-05

Review 6.  State of play in amyotrophic lateral sclerosis genetics.

Authors:  Alan E Renton; Adriano Chiò; Bryan J Traynor
Journal:  Nat Neurosci       Date:  2013-12-26       Impact factor: 24.884

Review 7.  Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature.

Authors:  A Chiò; G Logroscino; B J Traynor; J Collins; J C Simeone; L A Goldstein; L A White
Journal:  Neuroepidemiology       Date:  2013-07-11       Impact factor: 3.282

8.  Quantifying a nonnotifiable disease in the United States: the National Amyotrophic Lateral Sclerosis Registry model.

Authors:  D Kevin Horton; Paul Mehta; Vinicius C Antao
Journal:  JAMA       Date:  2014-09-17       Impact factor: 56.272

Review 9.  Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene.

Authors:  Peter M Andersen
Journal:  Curr Neurol Neurosci Rep       Date:  2006-01       Impact factor: 5.081

10.  State and metropolitan area-based amyotrophic lateral sclerosis (ALS) surveillance.

Authors:  Laurie Wagner; Lindsay Rechtman; Heather Jordan; Maggie Ritsick; Marchelle Sanchez; Eric Sorenson; Wendy Kaye
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2015-09-23       Impact factor: 4.092

  10 in total
  2 in total

1.  Keratinous biomarker of mercury exposure associated with amyotrophic lateral sclerosis risk in a nationwide U.S. study.

Authors:  Angeline S Andrew; Katie M O'Brien; Brian P Jackson; Dale P Sandler; Wendy E Kaye; Laurie Wagner; Elijah W Stommel; D Kevin Horton; Paul Mehta; Clarice R Weinberg
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2020-04-24       Impact factor: 4.092

2.  CDC Grand Rounds: National Amyotrophic Lateral Sclerosis (ALS) Registry Impact, Challenges, and Future Directions.

Authors:  Paul Mehta; D Kevin Horton; Edward J Kasarskis; Ed Tessaro; M Shira Eisenberg; Susan Laird; John Iskander
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-12-22       Impact factor: 17.586

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.